policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
In Short
Osteosarcoma is genetically similar in dogs and human children, according to a study published July 19 in the journal Communications Biology by Tufts…
JAVMA news
FDA gives conditional approval to canine lymphoma drug
The agency granted the conditional approval through the Minor Use/Minor Species regulatory pathway, which lets companies sell treatments for uncommon…
AVMA news
Shortage of cancer drugs having devastating effects on patients, veterinarians
Chemotherapy drugs, including cisplatin and carboplatin, have been in short supply for months. The situation is affecting animal patients and…
AVMA news
Drug approved to treat dogs for chemotherapy-related diarrhea
Food and Drug Administration officials granted conditional approval in mid-December for the oral prescription drug Canalevia-CA1, the first drug with…
JAVMA news
The continuing conundrum of feline injection-site sarcomas
Veterinarians would much rather talk with cat owners about all the advantages of vaccination for cats rather than the extremely rare occurrence of…